Multicenter randomized controlled trial of neoadjuvant chemoradiotherapy alone or in combination with pembrolizumab in patients with resectable or borderline resectable pancreatic adenocarcinoma
Matthew H.G. Katz, Gina R. Petroni, Todd Bauer, Matthew J. Reilley, Brian M. Wolpin, Chee Chee Stucky, Tanios S. Bekaii-Saab, Rawad Elias, Nipun Merchant, Andressa Dias Costa, Patrick Lenehan, Victoire Cardot-Ruffino, Scott Rodig, Kathleen Pfaff, Stephanie K. Dougan, Jonathan Andrew Nowak, Gauri R. Varadhachary, Craig L. Slingluff, Osama Rahma
Research output: Contribution to journal › Article › peer-review
Fingerprint
Dive into the research topics of 'Multicenter randomized controlled trial of neoadjuvant chemoradiotherapy alone or in combination with pembrolizumab in patients with resectable or borderline resectable pancreatic adenocarcinoma'. Together they form a unique fingerprint.